EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PINK1 is a target of T cell responses in Parkinson’s disease

Gregory P Williams, Antoine Freuchet, Tanner Michaelis, April Frazier, Ngan K Tran, João Rodrigues Lima-Junior, Elizabeth J Phillips, Simon A Mallal, Irene Litvan, Jennifer G Goldman, Roy N Alcalay, John Sidney und 3 weitere

Journal of Clinical Investigation · 2025

DOI: 10.1172/jci180478 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2025. Verfasst von Gregory P Williams und 14 weiteren Autor:innen. Beteiligte Einrichtung: Center for Autoimmunity and Inflammation, La Jolla Institute for Immunology, La Jolla, California, USA. Hauptthemen laut MEDLINE: Parkinson Disease, Protein Kinases, T-Lymphocytes. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NIAID NIH HHS, Alingning Science Across Parkinson’s.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson’s disease (PD) is the second most prevalent neurodegenerative disorder. While there is no curative treatment, the immune system’s involvement with autoimmune T cells that recognize the protein α-synuclein (α-syn) in a subset of individuals suggests new areas for therapeutic strategies. As not all patients with PD have T cells specific for α-syn, we explored additional autoantigenic targets of T cells in PD. We generated 15-mer peptides spanning several PD-related proteins implicated in PD pathology, including glucosylceramidase β 1 (GBA), superoxide dismutase 1 (SOD1), PTEN induced kinase 1 (PINK1), Parkin RBR E3 ubiquitin protein ligase (parkin), oxoglutarate dehydrogenase (OGDH), and leucine rich repeat kinase 2 (LRRK2). Cytokine production (IFN-γ, IL-5, IL-10) against these proteins was measured using a fluorospot assay and PBMCs from patients with PD and age-matched healthy controls. We identified PINK1, a regulator of mitochondrial stability, as an autoantigen targeted by T cells, as well as its unique epitopes, and their HLA restriction. The PINK1-specific T cell reactivity revealed sex-based differences, as it was predominantly found in male patients with PD, which may contribute to the heterogeneity of PD. Identifying and characterizing PINK1 and other autoinflammatory targets may lead to antigen-specific diagnostics, progression markers, and/or novel therapeutic strategies for PD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseProtein KinasesT-LymphocytesHumansFemaleMaleAgedMiddle Agedalpha-SynucleinPTEN-Induced Putative Kinase

Stichwörter der Autor:innen

Adaptive immunityAutoimmunityImmunologyParkinson diseaseT cells

Substanzen

Protein Kinasesalpha-SynucleinPTEN-Induced Putative Kinase

Autor:innen und Institutionen

  • Center for Autoimmunity and Inflammation, La Jolla Institute for Immunology, La Jolla, California, USA.
  • Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, Maryland, USA.
  • Department of Neurology, Columbia University, Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, New York, USA.
  • Institute for Immunology and Infectious Diseases, Murdoch University, Perth, Western Australia, Australia.
  • Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
  • Department of Neuroscience, UCSD, La Jolla, California, USA.

Förderung

  • NINDS NIH HHS
  • NIAID NIH HHS
  • Alingning Science Across Parkinson’s
  • National Institute of Neurological Disorders and Stroke
  • NIH
  • WHAM Investigator’s fund

Zitieren

APA

Williams, G. P., Freuchet, A., Michaelis, T., Frazier, A., Tran, N. K., Rodrigues Lima-Junior, J., Phillips, E. J., Mallal, S. A., Litvan, I., Goldman, J. G., Alcalay, R. N., Sidney, J., Sulzer, D., Sette, A., & Lindestam Arlehamn, C. S. (2025). PINK1 is a target of T cell responses in Parkinson’s disease. Journal of Clinical Investigation. https://doi.org/10.1172/jci180478

Vancouver

Williams GP, Freuchet A, Michaelis T, Frazier A, Tran NK, Rodrigues Lima-Junior J, et al. PINK1 is a target of T cell responses in Parkinson’s disease. Journal of Clinical Investigation. 2025. doi:10.1172/jci180478

BibTeX
@article{Williams2025,
  author = {Williams, Gregory P and Freuchet, Antoine and Michaelis, Tanner and Frazier, April and Tran, Ngan K and Rodrigues Lima-Junior, João and Phillips, Elizabeth J and Mallal, Simon A and Litvan, Irene and Goldman, Jennifer G and Alcalay, Roy N and Sidney, John and Sulzer, David and Sette, Alessandro and Lindestam Arlehamn, Cecilia S},
  title = {PINK1 is a target of T cell responses in Parkinson’s disease},
  journal = {Journal of Clinical Investigation},
  year = {2025},
  doi = {10.1172/jci180478}
}
Kostenlos starten →